The FBXL19 rs10782001 (G > A, C) polymorphism was evaluated in a study of predictive biomarkers for the risk of developing toxicity and/or paradoxical psoriasis due to anti-TNF drugs in Spanish patients with moderate-to-severe psoriasis (n = 161) [87]. The gene discussed is FBXL19; the disease is psoriasis.